From 118 kg to a new life: A doctor’s journey with obesity drugs
Daewoong secures US patent allowance for anti-aging mRNA technology
Celltrion expands Japan push with SteQeyma IV launch
SK Biopharmaceuticals settles first US patent dispute over Xcopri
Celltrion’s record quarter sparks target-price upgrades
Alteogen lands $365m licensing deal
Matica Bio zeroes in on bridging global biotech with Korea
Daewoong's botulinum toxin Nabota enters Kuwait
Yuhan brings DangQLac to Mexico in Latin America push
Celltrion to unveil obesity drug milestone before year-end
MORE
Aug. 21, 2026
Aug. 6, 2026
July 30, 2026
July 30, 2026
